ID
14828
Description
Randomized Phase III Study Of Exemestane (Aromasin) For 5 Years Versus Tamoxifen for 2.5 to 3 Years Followed By Exemestane; ODM derived from: https://clinicaltrials.gov/show/NCT00036270
Link
https://clinicaltrials.gov/show/NCT00036270
Keywords
Versions (1)
- 5/1/16 5/1/16 -
Uploaded on
May 1, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Breast Neoplasms NCT00036270
Eligibility Breast Neoplasms NCT00036270
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
ID.3
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0038894
- UMLS CUI [1,2]
- C1276305
Description
ID.4
Data type
boolean
Alias
- UMLS CUI [1]
- C0278601
Description
ID.5
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0229730
- UMLS CUI [1,2]
- C0019638
Description
ID.6
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0027627
- UMLS CUI [1,2]
- C1123023
- UMLS CUI [1,3]
- C0041582
- UMLS CUI [1,4]
- C0332448
Description
ID.7
Data type
boolean
Alias
- UMLS CUI [1,1]
- C0600558
- UMLS CUI [1,2]
- C3665472
Description
ID.8
Data type
boolean
Alias
- UMLS CUI [1]
- C0007124
- UMLS CUI [2]
- C0279563
Description
ID.9
Data type
boolean
Alias
- UMLS CUI [1]
- C2919271
- UMLS CUI [2]
- C2919590
Similar models
Eligibility Breast Neoplasms NCT00036270
- StudyEvent: Eligibility
C0679557 (UMLS CUI [1,2])
C0728940 (UMLS CUI [2])
C1522449 (UMLS CUI [3])
C0392920 (UMLS CUI [4])
C1276305 (UMLS CUI [1,2])
C0019638 (UMLS CUI [1,2])
C1123023 (UMLS CUI [1,2])
C0041582 (UMLS CUI [1,3])
C0332448 (UMLS CUI [1,4])
C3665472 (UMLS CUI [1,2])
C0279563 (UMLS CUI [2])
C2919590 (UMLS CUI [2])